| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f4315c828a4d2d2ad232787d2ed290a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6f73eea74d83b9189d140a18f9e3fc |
| publicationDate |
2011-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110015448-A |
| titleOfInvention |
TPO mimetic peptides for preventing blood diseases associated with cancer treatment |
| abstract |
The present invention provides a method of treating blood diseases such as anemia and thrombocytopenia, wherein the TPO mimetic peptide compound is administered using a particular dosage regimen. Dosage regimens involve administering the TPO mimetic peptide compound within a specific time frame near the administration of the chemotherapeutic agent. Dosage regimens also include monitoring the subject response to determine future treatment courses. |
| priorityDate |
2008-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |